This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Prostate-specific membrane antigen (PSMA) PET imaging could improve the length and quality of life for patients with recurrent prostate cancer, according to a study published October 23 in JAMA Network Open. In a modeling study of simulated patients, compared with conventional imaging, PSMA-PET was estimated to lead to fewer deaths from prostate cancer, more life years, and more quality-adjusted life years (QALYs) per 1,000 patients.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
The increased follow-up of recommended imaging exams combined with the efficiency owed to its use also generated an additional $9,000 in revenue per month at one organization.
ECOG-ACRIN Cancer Research Group and Caris Life Sciences have embarked on a multiyear research collaboration for biomarker analysis of 10,000 tumor tissue samples from the TAILORx breast cancer trial. Leading the project are Mitchell Schnall, MD, PhD, and Peter O'Dwyer, MD. Both are co-chairs of the ECOG-ACRIN Cancer Research Group and both are from the University of Pennsylvania in Philadelphia.
China has faced significant challenges improving breast cancer surveillance, including radiologist shortages and poor-quality screening methods, experts wrote in AJR.
Atlanta-based AI software company Inflo Health has joined the American College of Radiology’s (ACR) Learning Network after qualifying for it through the college's ImPower program. The achievement follows a successful initiative to improve imaging follow-up rates at East Alabama Medical Center (EAMC), Inflo said. Using its AI software, which was integrated into existing workflows at EAMC, completion rates for recommended lung nodule follow-ups increased by 74%, supported a 20% improvement in adhe
After only one to three days of a whiplash injury, scientists can predict which patients will develop chronic pain based on the extent of cross 'talk' between two regions of the brain, and the person's anxiety level after the injury, according to a new study. The study showed the more the hippocampus -- the brain's memory center -- talked to the cortex -- involved in long term memory storage -- the more likely the person is to develop chronic pain.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Despite reported issues with CT scanning interfering with certain medical devices, the U.S. Food and Drug Administration (FDA) has said CT is still the preferred imaging modality for patients with medical devices. In an October 15 communication , the agency said it had received reports of electronic medical devices being damaged during CT scans due to radiation.
GE HealthCare (GEHC) plans to install its 100th Omni Legend digital PET/CT in the U.S. at the newly completed University of Wisconsin (UW) Health Eastpark Medical Center in Madison. Additionally, less than a year after joining the Wisconsin BioHealth Tech Hub, GE HealthCare is advancing the first North American production line for the system in Waukesha, WI.
The updated software reportedly provides access to more than 200 enhanced features including optimized hanging protocols with a cardiac MRI viewer and perfusion quantification analysis.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Toronto, Ontario, Canada-based Ventripoint Diagnostics has received CE Mark certification for its VMS+4.0 automated cardiac ultrasound software. The certification will allow Ventripoint to engage in the next steps of country-specific introduction of VMS+4.0 in the European Union. VMS+4.0 offers automation of the image processing steps, which the company said can lead to a reduction in operator time without compromising the accuracy of the measurements.
Recently, 331 radiologists provided a glimpse into vRad by participating in Gallagher’s nationally benchmarked engagement survey of 12,000 radiologists.
France-based Median Technologies is reporting revenue increases for the third quarter of the 2024 fiscal year, which ended on September 30. The company reported a quarterly revenue of 6.2 million euros ($6.7 million), second highest ever for Median, up 10.7% versus the same quarter in 2023. Additionally, Median reported a total year-to-date revenue of 17.1 million euros ($18.5 million).
For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
The U.S. Food and Drug Administration (FDA) has accepted radiopharma company Telix's new drug application (NDA) for TLX101-CDx (Pixclara), an agent for glioma imaging. The FDA granted application priority review and designated a Prescription Drug User Fee Act (PDUFA) goal date of April 26, 2025, paving the way for a U.S. commercial launch for next year.
The healthcare sector continues to be deeply turbulent. Inflationary pressures, political uncertainty, and technological advances—like those presented by Artificial Intelligence (AI)—are causing a great deal of disruption. At the same time, provider issues caused by staff shortages and the remnants of the COVID-19 pandemic remain deeply problematic.
The University of California, San Francisco (UCSF) Department of Radiology and Biomedical Imaging is excited to welcome Sunit Davda, MBBS, to our Pediatric Imaging faculty.
Written by: Robyn Hadley, A.S., R.T.(R)(M)(ARRT) My radiologist is reading off-site now! What are the regulations and requirements to remain compliant? How do I acquire all the necessary information? How can I make sure I have and maintain documentation to satisfy my inspector? The use of telemammography has the potential to improve healthcare delivery and access by uniting patients with breast specialists (Chung and Parikh, 2020).
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Personalized medicine is a tailored approach to treating patients. Also called precision medicine, this model identifies patients through grouping according to their needs. Thanks to new diagnostic approaches, patients can be grouped according to the biomarkers identified through imaging, providing a deeper understanding of the molecular basis of their disease and the appropriate course of treatment.
Researchers are testing a novel imaging technique for breast cancer detection that they hope will eventually serve as a better alternative to the traditional mammogram.
Researchers are testing a novel imaging technique for breast cancer detection that they hope will eventually serve as a better alternative to the traditional mammogram.
Weight bearing CT (WBCT) imaging has fundamentally changed the evaluation and management of foot and ankle disorders such as hallux valgus, progressive collapsing foot disorder (PCFD), ankle instability, and traumatic deformities. The following panelists of experts share their insights and experiences in the use of WBCT in clinical practice as well as the future direction of the modality.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
321 
Let's personalize your content